Leo Lee Tsai, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lymphedema | 14 | 2023 | 534 | 4.050 |
Why?
|
Lymphatic Vessels | 5 | 2023 | 353 | 1.750 |
Why?
|
Lymphography | 7 | 2023 | 201 | 1.580 |
Why?
|
Liver Neoplasms | 6 | 2024 | 4253 | 1.060 |
Why?
|
Carcinoma, Hepatocellular | 4 | 2024 | 2214 | 0.930 |
Why?
|
Magnetic Resonance Imaging | 24 | 2024 | 35425 | 0.780 |
Why?
|
Asymptomatic Diseases | 1 | 2022 | 551 | 0.690 |
Why?
|
Helium | 3 | 2008 | 123 | 0.680 |
Why?
|
Pancreatitis | 2 | 2023 | 1092 | 0.650 |
Why?
|
Organometallic Compounds | 1 | 2021 | 665 | 0.620 |
Why?
|
Upper Extremity | 5 | 2023 | 648 | 0.600 |
Why?
|
Vaginal Neoplasms | 1 | 2018 | 106 | 0.600 |
Why?
|
Neuroendocrine Tumors | 1 | 2021 | 594 | 0.530 |
Why?
|
Carcinoma, Renal Cell | 2 | 2020 | 3143 | 0.520 |
Why?
|
Splenosis | 1 | 2014 | 4 | 0.520 |
Why?
|
Radiology | 3 | 2020 | 2099 | 0.510 |
Why?
|
Posture | 3 | 2008 | 958 | 0.480 |
Why?
|
Kidney Neoplasms | 2 | 2020 | 4262 | 0.470 |
Why?
|
Gallbladder Neoplasms | 1 | 2014 | 182 | 0.440 |
Why?
|
Vagina | 1 | 2018 | 825 | 0.430 |
Why?
|
Pancreatic Neoplasms | 4 | 2023 | 5263 | 0.420 |
Why?
|
Neurofibroma, Plexiform | 1 | 2012 | 71 | 0.400 |
Why?
|
Sulfonamides | 1 | 2020 | 1940 | 0.390 |
Why?
|
Arm | 3 | 2023 | 589 | 0.380 |
Why?
|
Nerve Sheath Neoplasms | 1 | 2012 | 191 | 0.360 |
Why?
|
Pyrimidines | 1 | 2020 | 2943 | 0.320 |
Why?
|
Spleen | 1 | 2014 | 2362 | 0.320 |
Why?
|
Myocardial Perfusion Imaging | 1 | 2013 | 554 | 0.310 |
Why?
|
Coronary Circulation | 1 | 2013 | 1572 | 0.300 |
Why?
|
Lymphatic System | 3 | 2023 | 252 | 0.290 |
Why?
|
Transducers | 1 | 2008 | 252 | 0.290 |
Why?
|
Neurofibromatosis 1 | 1 | 2012 | 570 | 0.280 |
Why?
|
Carcinoma | 1 | 2018 | 2375 | 0.280 |
Why?
|
Lower Extremity | 3 | 2023 | 1158 | 0.270 |
Why?
|
Carcinoma, Pancreatic Ductal | 3 | 2022 | 1636 | 0.260 |
Why?
|
Artifacts | 1 | 2013 | 1904 | 0.250 |
Why?
|
Omentum | 2 | 2023 | 170 | 0.240 |
Why?
|
Protein Kinase Inhibitors | 1 | 2020 | 5534 | 0.240 |
Why?
|
Indocyanine Green | 2 | 2022 | 239 | 0.240 |
Why?
|
Isotopes | 3 | 2008 | 124 | 0.230 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2012 | 2016 | 0.220 |
Why?
|
Prostate | 2 | 2021 | 1775 | 0.220 |
Why?
|
Breast Neoplasms | 4 | 2023 | 20824 | 0.220 |
Why?
|
Lactates | 1 | 2024 | 432 | 0.220 |
Why?
|
Pyruvic Acid | 1 | 2024 | 200 | 0.220 |
Why?
|
Phosphofructokinase-2 | 1 | 2022 | 32 | 0.220 |
Why?
|
Rats, Inbred F344 | 1 | 2024 | 862 | 0.220 |
Why?
|
Lymph Nodes | 4 | 2023 | 3476 | 0.210 |
Why?
|
Middle Aged | 21 | 2024 | 213390 | 0.210 |
Why?
|
Spin Labels | 2 | 2020 | 332 | 0.210 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2012 | 2943 | 0.200 |
Why?
|
Positron-Emission Tomography | 2 | 2021 | 6234 | 0.200 |
Why?
|
Abdominal Cavity | 1 | 2022 | 52 | 0.200 |
Why?
|
Humans | 42 | 2024 | 744366 | 0.200 |
Why?
|
Retrospective Studies | 16 | 2023 | 77460 | 0.200 |
Why?
|
Gallium Radioisotopes | 1 | 2021 | 178 | 0.190 |
Why?
|
Lung | 3 | 2008 | 9857 | 0.190 |
Why?
|
Carcinoma, Adenosquamous | 1 | 2020 | 68 | 0.190 |
Why?
|
Quality of Life | 3 | 2021 | 12802 | 0.180 |
Why?
|
Appendiceal Neoplasms | 1 | 2022 | 146 | 0.180 |
Why?
|
Postoperative Complications | 1 | 2022 | 15297 | 0.180 |
Why?
|
Female | 24 | 2024 | 380193 | 0.180 |
Why?
|
Heart | 1 | 2013 | 4464 | 0.180 |
Why?
|
Cholangiopancreatography, Magnetic Resonance | 1 | 2019 | 101 | 0.170 |
Why?
|
Edema | 1 | 2023 | 789 | 0.170 |
Why?
|
Lipectomy | 1 | 2020 | 118 | 0.170 |
Why?
|
Indazoles | 1 | 2020 | 290 | 0.170 |
Why?
|
Cryosurgery | 1 | 2023 | 453 | 0.160 |
Why?
|
Pancreas | 2 | 2023 | 1687 | 0.160 |
Why?
|
Glycolysis | 1 | 2022 | 829 | 0.160 |
Why?
|
Rats | 3 | 2024 | 24252 | 0.160 |
Why?
|
alpha-Fetoproteins | 1 | 2018 | 224 | 0.160 |
Why?
|
Ultrasonography, Doppler, Duplex | 1 | 2018 | 205 | 0.150 |
Why?
|
Prostatic Hyperplasia | 1 | 2021 | 523 | 0.150 |
Why?
|
Free Tissue Flaps | 1 | 2022 | 328 | 0.150 |
Why?
|
Radionuclide Imaging | 1 | 2021 | 2031 | 0.150 |
Why?
|
Lactic Acid | 1 | 2022 | 1132 | 0.150 |
Why?
|
Image Enhancement | 1 | 2008 | 2921 | 0.150 |
Why?
|
Perineum | 1 | 2018 | 211 | 0.140 |
Why?
|
Extremities | 1 | 2021 | 866 | 0.140 |
Why?
|
Hyperglycemia | 1 | 2024 | 1373 | 0.130 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2008 | 3326 | 0.130 |
Why?
|
Diagnosis, Differential | 3 | 2020 | 12961 | 0.120 |
Why?
|
Urologic Neoplasms | 1 | 2018 | 318 | 0.120 |
Why?
|
Device Approval | 1 | 2015 | 163 | 0.120 |
Why?
|
Male | 17 | 2023 | 350115 | 0.110 |
Why?
|
Splenectomy | 1 | 2014 | 395 | 0.110 |
Why?
|
Aged | 8 | 2023 | 163288 | 0.110 |
Why?
|
Attitude to Computers | 1 | 2013 | 202 | 0.110 |
Why?
|
Acute Disease | 1 | 2023 | 7147 | 0.110 |
Why?
|
Risk Management | 1 | 2015 | 571 | 0.100 |
Why?
|
Prospective Studies | 6 | 2022 | 53290 | 0.100 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2020 | 2455 | 0.100 |
Why?
|
Computers, Handheld | 1 | 2013 | 208 | 0.100 |
Why?
|
Equipment Design | 3 | 2008 | 3582 | 0.100 |
Why?
|
Cross-Sectional Studies | 3 | 2020 | 25039 | 0.090 |
Why?
|
Contrast Media | 3 | 2021 | 5300 | 0.090 |
Why?
|
Computer-Assisted Instruction | 1 | 2013 | 365 | 0.090 |
Why?
|
Prostatic Neoplasms | 2 | 2023 | 11126 | 0.090 |
Why?
|
Insulin | 1 | 2024 | 6582 | 0.080 |
Why?
|
Radiography | 1 | 2020 | 7023 | 0.080 |
Why?
|
Occupational Health | 1 | 2015 | 808 | 0.080 |
Why?
|
Sensitivity and Specificity | 2 | 2020 | 14723 | 0.080 |
Why?
|
Prostheses and Implants | 1 | 2015 | 1387 | 0.080 |
Why?
|
Administration, Inhalation | 2 | 2008 | 1105 | 0.080 |
Why?
|
Trachea | 1 | 2014 | 1076 | 0.080 |
Why?
|
Catheter Ablation | 1 | 2021 | 2758 | 0.080 |
Why?
|
Glucose | 1 | 2019 | 4398 | 0.070 |
Why?
|
Aortic Aneurysm, Thoracic | 1 | 2014 | 691 | 0.070 |
Why?
|
Cell Proliferation | 1 | 2022 | 10483 | 0.070 |
Why?
|
Diagnostic Imaging | 1 | 2020 | 3508 | 0.070 |
Why?
|
Equipment Failure Analysis | 1 | 2008 | 868 | 0.070 |
Why?
|
Intubation, Intratracheal | 1 | 2014 | 1364 | 0.070 |
Why?
|
Adult | 6 | 2023 | 214052 | 0.060 |
Why?
|
Immunohistochemistry | 1 | 2018 | 11366 | 0.060 |
Why?
|
Treatment Outcome | 4 | 2023 | 63107 | 0.060 |
Why?
|
Body Mass Index | 1 | 2021 | 12721 | 0.060 |
Why?
|
Algorithms | 2 | 2021 | 13882 | 0.060 |
Why?
|
Aging | 1 | 2021 | 8664 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 4 | 2023 | 20130 | 0.050 |
Why?
|
Animals | 3 | 2024 | 168768 | 0.050 |
Why?
|
Severity of Illness Index | 1 | 2020 | 15535 | 0.050 |
Why?
|
Aged, 80 and over | 3 | 2023 | 57776 | 0.050 |
Why?
|
Adenocarcinoma | 1 | 2019 | 6364 | 0.050 |
Why?
|
Radiopharmaceuticals | 1 | 2012 | 2645 | 0.050 |
Why?
|
Chronic Disease | 3 | 2022 | 9145 | 0.050 |
Why?
|
5-alpha Reductase Inhibitors | 1 | 2021 | 107 | 0.050 |
Why?
|
Elbow | 1 | 2021 | 138 | 0.050 |
Why?
|
Attitude of Health Personnel | 1 | 2013 | 3841 | 0.040 |
Why?
|
Mucins | 1 | 2022 | 564 | 0.040 |
Why?
|
Practice Guidelines as Topic | 1 | 2015 | 7282 | 0.040 |
Why?
|
Intraoperative Period | 1 | 2018 | 520 | 0.040 |
Why?
|
Pelvis | 1 | 2022 | 730 | 0.040 |
Why?
|
Organ Size | 1 | 2021 | 2251 | 0.040 |
Why?
|
Necrosis | 1 | 2020 | 1643 | 0.030 |
Why?
|
Workflow | 1 | 2021 | 847 | 0.030 |
Why?
|
Organoids | 1 | 2022 | 701 | 0.030 |
Why?
|
Adolescent | 3 | 2019 | 85779 | 0.030 |
Why?
|
Perfusion | 1 | 2019 | 1360 | 0.030 |
Why?
|
Imaging, Three-Dimensional | 1 | 2008 | 4042 | 0.030 |
Why?
|
Leg | 1 | 2019 | 1116 | 0.030 |
Why?
|
Mastectomy | 1 | 2023 | 1793 | 0.030 |
Why?
|
Goals | 1 | 2019 | 707 | 0.030 |
Why?
|
Microscopy, Fluorescence | 1 | 2021 | 2700 | 0.030 |
Why?
|
Pregnancy | 1 | 2015 | 29144 | 0.030 |
Why?
|
Prostate-Specific Antigen | 1 | 2023 | 2494 | 0.030 |
Why?
|
Feasibility Studies | 1 | 2023 | 5077 | 0.030 |
Why?
|
Internship and Residency | 1 | 2013 | 5791 | 0.030 |
Why?
|
Neoplasms | 1 | 2021 | 21696 | 0.030 |
Why?
|
Lymphatic Metastasis | 1 | 2019 | 2924 | 0.030 |
Why?
|
Hypoglycemic Agents | 1 | 2024 | 2873 | 0.030 |
Why?
|
Prognosis | 1 | 2012 | 29060 | 0.020 |
Why?
|
Thoracic Surgery, Video-Assisted | 1 | 2014 | 273 | 0.020 |
Why?
|
Infant | 1 | 2012 | 35134 | 0.020 |
Why?
|
Surgical Flaps | 1 | 2018 | 1640 | 0.020 |
Why?
|
Biopsy | 1 | 2021 | 6755 | 0.020 |
Why?
|
Blood Glucose | 1 | 2024 | 6254 | 0.020 |
Why?
|
Child, Preschool | 1 | 2012 | 41005 | 0.020 |
Why?
|
Young Adult | 1 | 2012 | 56429 | 0.020 |
Why?
|
Liver | 1 | 2021 | 7475 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2023 | 9240 | 0.020 |
Why?
|
Incidence | 1 | 2022 | 20952 | 0.010 |
Why?
|
Child | 1 | 2012 | 77709 | 0.010 |
Why?
|
Stents | 1 | 2014 | 3282 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2022 | 39052 | 0.010 |
Why?
|
Boston | 1 | 2013 | 9312 | 0.010 |
Why?
|
Endovascular Procedures | 1 | 2014 | 1980 | 0.010 |
Why?
|